Published in Health Business Week, May 27th, 2005
Net earnings for the first quarter were $13.8 million, or $0.35 per fully diluted share, up 133%, compared to the same period last year. The rise is attributable to increased revenue and margin expansion. The first-quarter 2005 results also included a $0.01 benefit related to currency derivatives.
Net revenue for the first quarter rose 28.1%, including a 3.7% increase related to foreign currency, to $192.5 million, compared to the first quarter of 2004. The growth in revenue reflected...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.